The Clinical Director of iCor, Prof. Antoni Bayés, Member of the European Commission who is developing the European Union Cardiovascular Health Plan
Professor Antoni Bayés, Clinical Director of the Germans Trias Heart Institute (iCor), has presented the European Union (EU) Cardiovascular Plan to the European Parliament, as a member of the European Commission’s Public Health Expert Group (PHEG). Cardiovascular diseases are the leading cause of death in the EU, with 1.7 million deaths each year, and this […]
Dr. Mª José Martínez, Cardiology Resident (2015-2020), defends her doctoral thesis
Dr. Maria José Martínez, Resident Physician at iCor during 2015 and 2020, has defended her doctoral thesis entitled ‘Analysis of the most frequent complications of acute myocardial infarction: from heart failure to atrial fibrillation.’ Mortality in the acute phase and long-term prognosis’. The Head of the Cardiology Service, Dr. Cosme Garcia, was the Director of […]
Excellent preliminary results among post-AMI patients included in the ATHENAS project
The Germans Trias Heart Institute (iCor) presented this Wednesday, November 19, the preliminary results achieved in the ATHENAS project , led by the Cardiology Service of the Germans Trias i Pujol University Hospital (HUGTiP) , and with the collaboration of the Endocrinology and Rehabilitation Service. The ATHENAS project ( ATHErosclerosis loweriNg As Soon as possible […]
The Arrhythmia Unit at Germans Trias incorporates pioneering technology in Catalonia for the treatment of cardiac arrhythmias
The Electrophysiology and Cardiac Arrhythmias Unit of the Heart Institute (iCor) of the Germans Trias i Pujol Hospital (HUGTiP) has successfully performed the first procedure in Catalonia with a state-of-the-art technology ablation system that combines, in a single catheter, the capacity for three-dimensional mapping and ablation using radiofrequency (heat) and electric field pulse energy ( […]
The first cardiac bioimplant developed to treat patients with myocardial infarction, the PeriCord
When a myocardial infarction occurs, blood stops circulating and properly nourishing the heart muscle cells. The heart loses strength to beat due to the death of cells in the injured area, which have stopped receiving blood from the coronary arteries. As a result of cell death, a permanent non-contractile scar is generated, which affects the […]
What is axillary access to the aortic valve?
The growth of percutaneous aortic valve implantation (TAVI) has driven the development of minimally invasive techniques for the implantation of conventional valves. The Cardiac Surgery Service of the Germans Trias i Pujol Hospital is a benchmark in this type of intervention, which involves less aggression for the patient. “The axillary access avoids fracturing the sternum, […]
iCor – IGTP and Boehringer Ingelheim strengthen their collaboration with preclinical research
The biopharmaceutical company Boehringer Ingelheim has signed a new collaboration agreement with the Germans Trias i Pujol Research Institute (IGTP) to launch a new research project focused on evaluating the potential benefit of a new molecule in the cardiovascular-renal-metabolic axis. The alliance between both institutions is part of a strategic collaboration initiated in 2020 between […]
The Heart Area of Germans Trias, the first health center in the State to participate with a patient in the international EASY-AS study
The Heart Institute of the Germans Trias i Pujol University Hospital (iCor) has been the first hospital in Spain to include a patient in the international EASY-AS study (Asymptomatic Aortic Estenosis). The main objective of this clinical trial is to establish an early aortic valve replacement strategy in asymptomatic patients with severe aortic stenosis that […]
The knowledge and research of the Heart Institute, at the 2025 Congress of The American College of Cardiology
Three studies with the active participation of the Heart Institute of the Germans Trias i Pujol Hospital (iCor) were presented at the 2025 Congress of the American College of Cardiology, organized in Chicago (United States). Among more than 4,000 scientific research proposals, ACC 2025 included in its scientific program three research studies carried out by […]
The first VASCRAFT bioimplant successfully applied
The consortium made up of the Blood and Tissue Bank (BST), the Germans Trias i Pujol Research Institute (IGTP) and IQS Barcelona has successfully performed the first vascular graft of biological origin, known as VASCRAFT, as a therapeutic and innovative alternative for coronary bypass in patients with coronary disease. The VASCRAFT project, formed by a […]
